» Articles » PMID: 37465952

Controlled Trial of a Workplace Sales Ban on Sugar-sweetened Beverages

Overview
Date 2023 Jul 19
PMID 37465952
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the effectiveness of a workplace sugar-sweetened beverage (SSB) sales ban on reducing SSB consumption in employees, including those with cardiometabolic disease risk factors.

Design: A controlled trial of ethnically diverse, full-time employees who consumed SSB heavily (sales ban 315; control 342). Outcomes included standardised measures of change in SSB consumption in the workplace (primary) and at home between baseline and 6 months post-sales ban.

Setting: Sutter Health, a large non-profit healthcare delivery system in Northern California.

Participants: Full-time employees at Sutter Health screened for heavy SSB consumption.

Results: Participants were 66·1 % non-White. On average, participants consumed 34·7 ounces (about 1 litre) of SSB per d, and the majority had an elevated baseline BMI (mean = 29·5). In adjusted regression analyses, those exposed to a workplace SSB sales ban for 6 months consumed 2·7 (95 % CI -4·9, -0·5) fewer ounces of SSB per d while at work, and 4·3 (95 % CI -8·4, -0·2) fewer total ounces per d, compared to controls. Sales ban participants with an elevated BMI or waist circumference had greater post-intervention reductions in workplace SSB consumption.

Conclusions: Workplace sales bans can reduce SSB consumption in ethnically diverse employee populations, including those at higher risk for cardiometabolic disease.

Citing Articles

Differential effect by chronic disease risk: A secondary analysis of the ChooseWell 365 randomized controlled trial.

Cheng J, Levy D, McCurley J, Rimm E, Gelsomin E, Thorndike A Prev Med Rep. 2024; 42:102736.

PMID: 38699077 PMC: 11063590. DOI: 10.1016/j.pmedr.2024.102736.


Did a workplace sugar-sweetened beverage sales ban reduce anxiety-related sugar-sweetened beverage consumption during the COVID-19 pandemic?.

Jacobs L, Schmidt L, Schillinger D, Schmidt J, Alegria K, Parrett B Public Health Nutr. 2024; 27(1):e139.

PMID: 38698591 PMC: 11374549. DOI: 10.1017/S1368980024000995.

References
1.
Orkin A, Gill P, Ghersi D, Campbell L, Sugarman J, Emsley R . Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement. JAMA. 2021; 326(3):257-265. DOI: 10.1001/jama.2021.9941. View

2.
Patel A, Schmidt L . Healthy beverage initiatives in higher education: an untapped strategy for health promotion. Public Health Nutr. 2020; 24(1):136-138. PMC: 10195485. DOI: 10.1017/S1368980020003766. View

3.
Krieger J, Bleich S, Scarmo S, Ng S . Sugar-Sweetened Beverage Reduction Policies: Progress and Promise. Annu Rev Public Health. 2020; 42:439-461. DOI: 10.1146/annurev-publhealth-090419-103005. View

4.
Xi B, Huang Y, Reilly K, Li S, Zheng R, Barrio-Lopez M . Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. Br J Nutr. 2015; 113(5):709-17. DOI: 10.1017/S0007114514004383. View

5.
Dai J, Soto M, Dunn C, Bleich S . Trends and patterns in sugar-sweetened beverage consumption among children and adults by race and/or ethnicity, 2003-2018. Public Health Nutr. 2021; 24(9):2405-2410. PMC: 10195631. DOI: 10.1017/S1368980021001580. View